New 340B Rule Lets Feds Fine Drugmakers for Overcharges

by admin | January 4, 2017 4:24 pm

January 4, 2017—The Department of Health and Human Services published a 340B program final rule today implementing fines for drug manufacturers that knowingly and intentionally overcharge safety-net healthcare providers. The rule also sets standards for calculating 340B ceiling prices.  


You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register[1].    Already registered? Click here to login[2]. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)

Endnotes:
  1. Click here to register: http://secure.340bhealth.org/imis/340Binformed/Subscribe/340Binformed/Subscribe.aspx?hkey=
  2. Click here to login: http://340binformed.org/reader-login/

Source URL: http://340binformed.org/2017/01/new-340b-rule-lets-feds-fine-drugmakers-for-overcharges/